NC to Receive $1.2 Million in Pfizer Settlement
The state of North Carolina will be receiving $1.2 million of a $35 million settlement between Pfizer and 41 other states.
Biopharmaceutical company, Pfizer, settled after North Carolina Attorney General Roy Cooper and his counterparts from other states said it unlawfully promoted Rapamune, a drug that was given to patients to help prevent rejection of kidney transplants.
Pfizer closed its Research Triangle Park and Stamford research and development offices about five years ago.
Cooper alleged that Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, engaged in unfair and deceptive practices by misrepresenting the uses and benefits of Rapamune, "Promoting a drug to treat a condition without proof that it could help patients is wrong," Cooper said in a statement released by his office. "Patients and their doctors deserve honest, accurate information about medications."
The $35 million recovered through the settlement will be shared among the 42 participating states. Under the settlement announced today, Pfizer will also reform its marketing and promotional practices so that it does not unlawfully promote Rapamune or any Pfizer product.